A Novel Targeted Microtubules Transformable Nanopeptide System Yields Strong Anti‐Prostate Cancer Effects by Suppressing Nuclear Translocation of Androgen Receptors
Advanced Materials · 2024
DOI: 10.1002/adma.202407826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Lu Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, 150001, China. Hauptthemen laut MEDLINE: Microtubules, Receptors, Androgen, Prostatic Neoplasms, Tubulin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Committees for Ethical Review of Harbin Medical University.
Abstract (Originalsprache)
The extended use of androgen deprivation therapy (ADT) may often lead to the progression from castration‐sensitive prostate cancer (CSPC) to castration‐resistant prostate cancer (CRPC) in prostate cancer. To address this, it is essential to inhibit the nuclear translocation of the androgen receptor (AR) as part of an effective disease‐modifying strategy. Microtubules play a central role in facilitating AR nuclear translocation, highlighting their importance as a therapeutic target. In this regard, a designated as the targeted microtubules transformable nanopeptide system (MTN) is developed. This system is designed to disrupt microtubule structure and function through dual‐targeting of prostate‐specific membrane antigen (PSMA) and β‐tubulin. Initially, MTN targets prostate cells via PSMA and then specifically binds to β‐tubulin within microtubules, leading to the formation of nanofibers. These nanofibers subsequently induce the polymerization of microtubules, thereby disrupting AR transport. Notably, MTN exhibits efficient and prolonged suppression of prostate cancer across the spectrum from CSPC to CRPC, with a highly favorable safety profile in normal cells. These findings highlight the potential of MTN as a novel and promising approach for comprehensive prostate cancer therapy throughout its entire progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, 150001, China.
- Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
- CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing, 10019…
- Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
ORCID-Profile: Wanhai Xu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Committees for Ethical Review of Harbin Medical University
- National Key Research and Development Program of China
Zitieren
APA
Wang, L., Kong, B., Wang, J., Yang, G., Wu, X., Zang, J., Li, C., Wang, X., Si, M., Wang, Z., Liu, P., Wang, Y., Chen, H., Liu, F., Yang, P. P., Wang, L., Wang, H., & Xu, W. (2024). A Novel Targeted Microtubules Transformable Nanopeptide System Yields Strong Anti‐Prostate Cancer Effects by Suppressing Nuclear Translocation of Androgen Receptors. Advanced Materials. https://doi.org/10.1002/adma.202407826
Vancouver
Wang L, Kong B, Wang J, Yang G, Wu X, Zang J, et al. A Novel Targeted Microtubules Transformable Nanopeptide System Yields Strong Anti‐Prostate Cancer Effects by Suppressing Nuclear Translocation of Androgen Receptors. Advanced Materials. 2024. doi:10.1002/adma.202407826
BibTeX
@article{Wang2024,
author = {Wang, Lu and Kong, Bin and Wang, Jiaqi and Yang, Guang and Wu, Xiuhai and Zang, Jiahui and Li, Cong and Wang, Xinyue and Si, Minggui and Wang, Zhijia and Liu, Pan and Wang, Yuting and Chen, Huilin and Liu, Feng and Yang, Pei-Pei and Wang, Lei and Wang, Hao and Xu, Wanhai},
title = {A Novel Targeted Microtubules Transformable Nanopeptide System Yields Strong Anti‐Prostate Cancer Effects by Suppressing Nuclear Translocation of Androgen Receptors},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202407826}
}
EUVIMED